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CASE REPORT
Fig. 1. A non-tender, fingernail-sized, grayish-brown, atrophic, 
shiny patch on the upper back.
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Aneurysmal benign fibrous histiocytoma is an uncommon 
pathologic variant of dermatofibroma. In addition to the 
features of a typical dermatofibroma, it has large cleft-like or 
cavernous blood-filled spaces with numerous hemosiderin 
pigments. It should be differentiated from angiomatoid 
malignant fibrous histiocytoma, malignant melanoma, and 
vascular tumors such as Kaposi's sarcoma and angiosar-
coma. Atrophic dermatofibroma is also a rare variant of 
dermatofibroma, and the combination of aneurysmal and 
atrophic features is rarer still. We report a case of aneurysmal 
benign fibrous histiocytoma with atrophic features in a 
27-year-old male who had a grayish-brown atrophic patchy 
lesion on his back for 2 years. (Ann Dermatol (Seoul) 21(1) 
42∼45, 2009)
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INTRODUCTION
Benign fibrous histiocytoma (BFH), also known as derma-
tofibroma (DF), is a common benign fibrohistiocytic lesion 
that usually occurs as a solitary nodule on the limbs of 
young to middle-aged adults. It has many clinico-
pathological variants and the diagnosis may therefore be 
difficult. Aneurysmal BFH is an uncommon histologic 
variant of BFH. It is usually larger than typical BFH and 
sometimes shows rapid growth. Atrophic DF is a rare 
variant of DF and presents as an atrophic or depressed 
patch with decreased thickness of the dermis, which is 
less than 50% of the surrounding dermis. We report a rare 
and interesting case that has both of these variant features.
CASE REPORT
A 27-year-old man visited our clinic with a 2-year history 
of a brownish patch on his back. He had swelling and 
pain of this lesion 1 year ago, but recently had no other 
symptoms. The patient had no specific past medical 
history or any pertinent family history, and there was no 
history of trauma. Physical examination revealed a 
non-tender, fingernail-sized, oval, grayish-brown, atro-
phic, shiny patch on the upper back (Fig. 1). Clinically, 
the lesion was initially thought to be a malignant 
melanoma or an inflamed seborrheic keratosis, and a skin 
biopsy was taken from the center of the lesion.
Histopathological findings revealed a non-encapsulated 
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Fig. 2. (A) Histopathological findings 
revealed a non-encapsulated, ill-de-
fined mass with numerous large 
pigments in the dermis without 
significant epidermal changes (H&E, 
×40). (B) Multiple cavernous angio-
matoid areas were surrounded by 
histiocytes, fibroblasts, pigments, 
and capillaries. Extravasated red 
blood cells and multinucleated giant 
cells were also observed (H&E, 
×200).
Fig. 3. The large pigments in tumor mass were positively stained
for iron (Prussian blue, ×200).
ill-defined mass with numerous large pigments in the 
dermis without significant epidermal changes. These 
pigments were positively stained for iron; hence they were 
hemosiderin pigments (Fig. 2). Multiple cavernous angio-
matoid areas were surrounded by histiocytes, fibroblasts, 
pigments, and capillaries. Extravasated red blood cells and 
multinucleated giant cells were also observed (Fig. 3). 
Immunohistochemical analysis showed that the tumor 
cells were strongly positive for vimentin, negative for 
S-100, HMB-45, CD68, and factor XIIIa, and focally 
positive but mainly negative for CD34 (Fig. 4). Con-
sidering both clinical and pathologic findings, the final 
diagnosis of aneurysmal BFH with atrophic features was 
established. The lesion was completely excised and there 
was no evidence of recurrence within 5 months after the 
removal.
DISCUSSION
BFH usually presents as single or multiple firm reddish- 
brown nodules located on the lower extremities of young 
adults. Histopathological findings show a tumor mass in 
the dermis that is composed of fibroblast-like spindle cells, 
histiocytes, and blood vessels.
Aneurysmal benign fibrous histiocytoma (ABFH) is an 
uncommon variant of BFH that was first described by 
Santa Cruz and Kyriakos in 19811. When compared with 
typical BFH clinically, the ABFH may be a larger lesion 
and may also be associated with symptoms of rapid 
growth and pain. It also has a higher local recurrence rate 
after removal of the lesion. According to a previous report, 
about 20% of ABFH lesions undergo abrupt or recent 
color changes2. In addition to the typical histopathological 
features of BFH, ABFH has findings such as collections of 
capillaries, hemorrhagic foci, and hemosiderin deposits 
around cleft-like and cavernous blood-filled spaces in the 
center of the tumor. ABFH is reported to be negative for 
immunohistochemical staining for factor XIIIa, CD34, 
CD31, CD68, and desmin, but strongly positive for vimen-
tin2.
Because of its diverse histologic appearance, ABFH is 
frequently confused with other fibrous or vascular tumors 
such as dermatofibrosarcoma protuberans (DFSP), spindle 
cell hemangioendothelioma, nodular Kaposi's sarcoma, 
and angiosarcoma. However, unlike DFSP, ABFH rarely 
invades the subcutaneous fatty layer and does not have a 
reticular pattern when it does invade the fatty layer. 
Moreover, DFSP tumor cells are mostly positive (92%) for 
CD34 immunohistochemically, while only a small portion 
of ABFH tumor cells are positive (42%) for CD343. In 
Kaposi's sarcoma, enlarged cystic structures are sur-
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Fig. 4. (A) Immunohistochemical 
staining was performed using the 
avidin-biotin complex method. Most 
of the tumor cells are strongly 
positive for vimentin (×200). (B) 
Endothelial cells lining the cavern-
ous spaces and tumor cells focally 
stain for CD34. However, the 
majority of tumor cells are negative 
for DC34 (×100).
rounded by the endothelium, and the tumor cells are 
positive for CD34 by immunohistochemical analysis. 
Angiosarcoma shows atypical proliferation of the 
endothelium, which is not observed in ABFH.
The exact pathogenesis of ABFH is not clear and remains 
controversial. There is no proven correlation between 
external trauma and the hemorrhagic features within the 
tissues4. Santa Cruz and Kyriakos1 reported that, in some 
cases of DF, blood slowly extravasates from the capillaries 
of the tumor and then produces hemosiderin pigments. 
This continuous extravasation of blood then supposedly 
fills the tissue spaces and finally forms cavernous or 
cleft-like areas that are characteristic of ABFH.
Atrophic DF was first described by Page and Assaad5 in 
1987, who reported five cases of depressed or atrophic DF 
and DFSP. Atrophic DF represents about 2% of all DF and 
commonly occurs on the upper trunk of women. Atrophic 
DF appears more frequently at older ages compared with 
typical DF (49 years vs. 20∼25 years of age) and has a 
higher female dominance6. While DF usually presents as 
firm reddish-brown papules with diameters of 0.5 cm to 
1.0 cm, atrophic DF appears as an anetoderma, or de-
pressed plaque. Histologically, atrophic DF is accom-
panied by dermal atrophy of more than 50% of the 
locoregional dermis7.
The exact cause of atrophic DF has been under debate. 
Kiyohara et al8 proposed that this disease might be caused 
by abnormal elastophagocytosis of collagen fibers by the 
cells of DF. On the other hand, Beer et al9 insisted that 
atrophic DF is an unusual type of late-stage DF because 
the mean age of atrophic DF is older than that of typical 
DF. Other diseases such as anetoderma, atrophic scar, 
morphea, sclerosing basal cell carcinoma, localized 
lipoatrophy, and steroid atrophy must be considered in 
differential diagnosis.
Our case displays aneurysmal characteristics with atrophy, 
which are both rare variants of DF. There is only one 
reported case similar to this case6. However, compared to 
the previous case, there was no loss of dermal tissue in 
our case and we suggest that "DF with atrophic features" 
is a more appropriate description of the present case than 
"atrophic DF". Two cases of DF with atrophic features 
have been reported in Korea, but these seem to have 
resulted from biopsies of an early-stage DF because of the 
short duration of the disease10. Herein we report a rare 
and interesting case of variant DF with both aneurysmal 
and atrophic characteristics, which is extremely difficult to 
diagnose clinically as a DF.
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